Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This is an 8 week study to assess the efficacy and safety profile of PF-06651600 in seropositive subjects with rheumatoid arthritis with an inadequate response to methotrexate (up to approximately 50% of subjects may also have had an inadequate response to 1 anti-TNF biologic).
Epistemonikos ID: d649f9df7ee7de280d910de07d311dff7f09fcd0
First added on: Mar 23, 2022